WFG Advisors’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$1K Hold
100
﹤0.01% 1480
2017
Q1
$1K Hold
100
﹤0.01% 1403
2016
Q4
$1K Buy
+100
New +$1.09K ﹤0.01% 1480
2016
Q3
Sell
-300
Closed -$3K 1620
2016
Q2
$3K Hold
300
﹤0.01% 1325
2016
Q1
$3K Sell
300
-700
-70% -$6.59K ﹤0.01% 1277
2015
Q4
$17K Hold
1,000
0.01% 933
2015
Q3
$13K Sell
1,000
-2,000
-67% -$40.2K ﹤0.01% 1018
2015
Q2
$68K Hold
3,000
0.02% 639
2015
Q1
$43K Hold
3,000
0.01% 765
2014
Q4
$29K Hold
3,000
0.01% 1098
2014
Q3
$27K Sell
3,000
-500
-14% -$4.76K 0.01% 1158
2014
Q2
$35K Sell
3,500
-1,750
-33% -$14.8K 0.01% 1047
2014
Q1
$67K Hold
5,250
0.01% 785
2013
Q4
$79K Buy
5,250
+3,250
+163% +$41.8K 0.01% 829
2013
Q3
$22K Hold
2,000
﹤0.01% 1236
2013
Q2
$16K Buy
+2,000
New +$12.7K ﹤0.01% 1289

Other funds holding HALO

WFG Advisors's HALO Position: Q2 2017 in Review

WFG Advisors held its Halozyme (HALO) position steady in Q2 2017 at 100 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1480.

WFG Advisors first reported a position in HALO in Q2 2013 and has held it in 16 quarters since. The position peaked at $79K in Q4 2013. 167 funds tracked by Wall St. Rank hold HALO as of Q2 2017.

  • WFG Advisors held 100 shares of Halozyme worth $1K as of Q2 2017.
  • WFG Advisors left its Halozyme share count unchanged in Q2 2017.
  • Halozyme made up ﹤0.01% of WFG Advisors's portfolio in Q2 2017, its #1480 holding.
  • WFG Advisors first reported a position in Halozyme in Q2 2013 and has held it in 16 quarters since.
  • WFG Advisors's Halozyme position peaked at $79K in Q4 2013.
  • 167 funds tracked by Wall St. Rank held Halozyme as of Q2 2017.

Based on WFG Advisors's 13F filing for Q2 2017, filed 18 Aug 2017.